Skip to main content

Table 2 Clinical stage, Pathological stage and response

From: Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study

  NCRT+MIE(n = 44) MIE alone(n = 63)
Clinical stage
  II 2 (4%) I 8 (13%)
III 25 (57%) II 51 (81%)
IV 17 (39%) III 4 (6%)
Pathological stage ypTNM pTNM
  I 21 (47%) IA 5 (8%)
II 5 (11%) IB 2 (3%)
IIIA 5 (11%) IIA 11 (18%)
IIIB 10 (22%) IIB 19 (31%)
IVA 4 (9%) IIIA 17 (26%)
  IIIB 7 (11%)
  IVA 2 (3%)
Response PR 19 (43%)  
  CR 21 (48%)  
SD 4 (9%)  
pCR 13 (29.55%)